These highlights do not include all the information needed to use INTRAROSA® safely and effectively. See full prescribing information for INTRAROSA®. INTRAROSA® (prasterone) vaginal inserts Initial U.S. Approval: 2016
Reference ID: 4014943
Prasterone | Uses, Brand Names, Mechanism Of Action
Prasterone (Intrarosa)
Intrarosa Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
Intrarosa Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
INTRAROSA® (prasterone) Vaginal Inserts: Official Website
Intrarosa: Package Insert - Drugs.com
Intrarosa Vaginal Inserts (Prasterone): Uses, Dosage, Side Effects, Interactions, Warning
Reference ID: 4014943
Intrarosa is the FIRST AND ONLY FDA-APPROVED NON-ESTROGEN THERAPY WITH PRASTERONE 1
Testosterone in Females | SpringerLink
Lupin Pharma Canada announces the availability of Intrarosa® (prasterone vaginal ovules), a new treatment option in Canada for women with postmenopausal vulvovaginal atrophy
Intrarosa - 4138 - EPAR AR
Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause
Untitled
Intrarosa Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
INTRAROSA® (prasterone) Vaginal Inserts: Official Website
These highlights do not include all the information needed to use INTRAROSA ® safely and effectively. See full prescribing information for INTRAROSA ®. INTRAROSA ® (prasterone) vaginal inserts Initial U.S. Approval: 2016
Intrarosa 6.5 mg pessary - Summary of Product Characteristics (SmPC) - (emc)
Intrarosa is the FIRST AND ONLY FDA-APPROVED NON-ESTROGEN THERAPY WITH PRASTERONE 1
analystdaydeck
Intrarosa: Package Insert - Drugs.com
Intrarosa Vaginal Inserts (Prasterone): Uses, Dosage, Side Effects, Interactions, Warning
Intrarosa is the FIRST AND ONLY FDA-APPROVED NON-ESTROGEN THERAPY WITH PRASTERONE 1
